| Structure | Chemical Name | CAS | MF |
|
N-(2-aminoethyl)-N-pyrazin-2-ylamine hydrochloride
|
|
C6H11ClN4
|
|
N-(5-Amino-2-methoxyphenyl)-3-phenylpropanamide
|
953900-11-3
|
C16H18N2O2
|
|
N-(4-Amino-2-methylphenyl)-4-isopropoxybenzamide
|
1020057-87-7
|
C17H20N2O2
|
|
N-(5-Amino-2-methoxyphenyl)butanamide
|
946710-33-4
|
C11H16N2O2
|
|
N-(3-Amino-2-methylphenyl)-2-(4-chloro-3,5-dimethylphenoxy)acetamide
|
1020056-26-1
|
C17H19ClN2O2
|
|
N-(5-Amino-2-methoxyphenyl)-4-methylbenzamide
|
926234-94-8
|
C15H16N2O2
|
|
N-(5-Amino-2-methylphenyl)-2-propoxybenzamide
|
1020723-93-6
|
C17H20N2O2
|
|
N-(4-Aminophenyl)-2-methylbenzamide
|
337499-57-7
|
C14H14N2O
|
|
N-(3-Amino-4-chlorophenyl)-2-(2-chlorophenoxy)-propanamide
|
1020055-01-9
|
C15H14Cl2N2O2
|
|
N-(5-Amino-2-methylphenyl)-2-[2-(sec-butyl)-phenoxy]propanamide
|
1020054-87-8
|
C20H26N2O2
|
|
N-(4-Amino-2-methylphenyl)-2-(4-methoxyphenyl)-acetamide
|
1016493-56-3
|
C16H18N2O2
|
|
N-(4-amino-2-methoxyphenyl)methanesulfonamide
|
|
C8H12N2O3S
|
|
N-(7-amino-1,1,3,3,6-pentamethyl-2,3-dihydro-1H-inden-5-yl)-N'-(4-methoxyphenyl)thiourea
|
|
C22H29N3OS
|
|
N-(5-Amino-2-methylphenyl)-2-(2-ethoxyethoxy)-benzamide
|
1020054-84-5
|
C18H22N2O3
|
|
N-(3-Amino-2-methylphenyl)-2-phenoxypropanamide
|
954253-86-2
|
C16H18N2O2
|
|
N-(3-Aminophenyl)-2-[4-(tert-butyl)phenoxy]-propanamide
|
1020722-89-7
|
C19H24N2O2
|
|
N-(3-Amino-4-chlorophenyl)-2-(2-chlorophenoxy)-acetamide
|
1020054-54-9
|
C14H12Cl2N2O2
|
|
Namirotene
|
101506-83-6
|
C17H18O2S
|
|
naltiazem
|
108383-95-5
|
C26H28N2O4S
|
|
NBD-5-acylcholine
|
70214-86-7
|
C17H26N5O5+
|
|
Naltrexone 3-Methyl Ether
|
16617-07-5
|
C21H25NO4
|
|
Naltrexone 2,3,4-Tri-O-acetyl-O-β-D-glucuronic Acid Methyl Ester
|
|
C33H39NO13
|
|
6β-Naltrexol-d4 3-O-β-D-Glucuronide
|
|
C26H33NO10
|
|
6β-Naltrexol 3-O-β-D-Glucuronide
|
1391506-73-2
|
C26H33NO10
|
|
NALTRINDOLE, [5',7'-3H]
|
|
C26H24N2O3T2
|
|
NALTREXONE USP(CRM STANDARD)
|
|
|
|
naltrexonazine
|
82823-99-2
|
C40H46N4O6
|
|
NALTRINDOLE ISOTHIOCYANATE HYDROCHLORIDE
|
|
C27H25N3O3S
|
|
Naltrexone methylbromide
|
73232-52-7
|
C21H26BrNO4
|
|
|
NALTRIBEN [3H]
|
|
|
|
|
Naltrexone internal Spec
|
|
|
|
NALTREXONE-D4
|
2070009-29-7
|
C20H23NO4
|
|
|
NALTREXONE FLUORESCEIN
|
|
|
|
Naltrexone hydrochloride
|
16676-29-2
|
C20H24ClNO4
|
|
|
6-β-Naltrexol-d4 HCl
|
|
C20H21D4NO4
|
|
|
Naltrexone-d4-3-glucuronide
|
|
C26H27D4NO10
|
|
NALTREXONE HYDROCHLORIDE DIHYDRATE
|
|
C20H28ClNO6
|
|
NALTRINDOLE HYDROCHLORIDE
|
111469-81-9
|
C26H27ClN2O3
|
|
NALTREXONE-3-GLUCURONIDE
|
76630-71-2
|
C26H31NO10
|
|
NALTRIBEN MESYLATE
|
111555-58-9
|
C26H25NO4
|
|
NALTREXONE-D3
|
1261080-26-5
|
C20H23NO4
|
|
Naltrexone-d3 3-O--D-Glucuronide
|
|
C26H31NO10
|
|
|
NALTREXONE MM(CRM STANDARD)
|
|
|
|
naltrexone-estrone azine
|
140188-23-4
|
C38H45N3O4
|
|
naltrexamine, N(beta)-(Leu-Arg-Arg-Leu-Phe)-
|
116764-29-5
|
C53H81N13O8
|
|
|
NALTREXONE RELATED COMPOUND A CII UBN-(3-BUTENYL)NOROXYMORPHONE HCL USP(CRM STANDARD)
|
|
|
|
Naltrexone
|
16590-41-3
|
C20H23NO4
|
|
|
Naltrexone-d3 3-O-b-D-Glucuronide
|
|
|
|
Naltrindol
|
111555-53-4
|
C26H26N2O3
|
|
naltrexone phenyl oxime
|
115160-07-1
|
C26H28N2O4
|
|
naltrexone-3-salicylate
|
110189-11-2
|
C27H27NO6
|
|
naltrexazone
|
73674-86-9
|
C20H25N3O3
|
|
NALTREXONE-3-GLUCURONIDE-D4
|
|
C26H27D4NO10
|
|
Naltrexone Impurity
|
607732-61-6
|
C40H44N2O8
|
|
NALTRINDOLE ISOTHIOCYANATE
|
126876-64-0
|
C27H25N3O3S
|
|
|
Naltrexone 14-acetate
|
|
|
|
|
NBD-Aminohexanoylaminophenethylspiperone
|
|
C43H47FN8O6HCl
|
|
|
NBD Amine
|
|
|
|
|
nanaomycin B synthetase
|
|
|
|
Nanaomycin B
|
52934-85-7
|
C16H16O7
|
|
Nanaomycin C
|
58286-55-8
|
C16H15NO5
|
|
NANAOMYCIN A
|
52934-83-5
|
C16H14O6
|
|
Nanaomycin E
|
72660-52-7
|
C16H14O7
|
|
|
nanaomycin A monooxygenase (4a,10a-epoxidizing)
|
|
|
|
|
nanaomycin D reductase
|
|
|
|
Nanaomycin A methyl ester
|
58286-56-9
|
C17H16O6
|
|
NA-(2-NAPHTHALENESULFONYLGLYCYL)-4-AMIDINO-D,L-PHENYLALANINEPIPERIDIDE
|
86125-48-6
|
C27H31N5O4S
|
|
N-a-Naphtyl thiourea
|
|
C11H10N2S
|
|
|
NBD-BINDING PEPTIDE, CELL-PERMEABLE, NEGATIVE CONTROL
|
|
|
|
N-BDAVBi , N-(4-((E)-2-(6-((E)-4-(diphenylaMino)styryl)naphtha
|
1032556-63-0
|
C50H38N2
|
|
|
NBD C6-CERAMIDE COMPLEXED TO BSA
|
|
|
|
|
NBD-cerebroside
|
|
|
|
|
NaN channel
|
|
|
|
|
NBC1 (Na, HCO3 Cotransporter 1, pNBC)
|
|
|
|
|
NBC1 (Na, HCO3 Cotransporter 1)
|
|
|
|
|
NBC3 (Na, HCO3 Cotransporter 3)
|
|
|
|
|
NBC1 (Na, HCO3 Cotransporter 1, pNBC) C
|
|
|
|
|
NBC (Na, HCO3 Cotransporter) C
|
|
|
|
|
NBC (Na, HCO3 Cotransporter) A
|
|
|
|
|
NBC (Na, HCO3 Cotransporter) D
|
|
|
|
|
NBC1 (Na, HCO3 Cotransporter 1, pNBC) A
|
|
|
|
|
NBC3 (Na, HCO3 Cotransporter 3) A
|
|
|
|
|
NBC1 (Na, HCO3 Cotransporter 1, pNBC) D
|
|
|
|
|
NBC (Na, HCO3 Cotransporter)
|
|
|
|
|
NBC1 (Na, HCO3 Cotransporter 1, pNBC) B
|
|
|
|
|
NBC (Na, HCO3 Cotransporter) B
|
|
|
|
NBD D-erythro-Sphingosine
|
|
C24H39N5O5
|
|
1-NBD-decanoyl-2-decanoyl-sn-Glycerol
|
2309189-98-6
|
C29H46N4O8
|
|
NBD-COCL
|
140164-85-8
|
C9H7ClN4O4
|
|
|
N(6)-(2-((4-ammonio-5-oxido--5-oxopentyl)amino)-5-(2,3-dihydroxypropyl)-3,5-dihydro-4H-imidazol-4-ylidene)lysinate
|
|
|
|
N-(2-ammonioethyl)ethane-1,2-diammonium trifluoride
|
68444-11-1
|
C4H16F3N3
|
|
|
N1-[1-ammonio-1-(4-bromobenzyl)-lambda~4~-sulfanyl]aniline bromide
|
|
|
|
|
N(6)-(2-((4-ammonio-5-oxido-5-oxopentyl)amino)-5-(2,3,4-trihydroxybutyl)3,5-dihydro-4H-imidazol-4-ylidene)lysinate
|
|
|
|
1-(N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate
|
|
C6H16N4O2
|
|
|
NBC1, MOUSE, 20AA WITHIN CYTOPLASMIC CT
|
|
|
|
N-(2-ammonioethyl)ethylenediammonium tris[tetrafluoroborate(1-)]
|
68025-47-8
|
C4H16B3F12N3
|
|
N-(2-ammonioethyl)ethane-1,2-diammonium phosphate
|
14852-18-7
|
C4H16N3O4P
|
|
NBD-CO-HZ
|
221263-97-4
|
C9H10N6O4
|
|
NBD-DEMECOLCIN
|
108964-31-4
|
C27H26N4O8
|
|
|
15N-Ammonium Nitrate-15N
|
|
15NH415NO3
|